Figure 2. Age at disease and myoclonus onset in patients with undetermined progressive myoclonic epilepsies belonging to clusters 1 and 2.

Note that most of the patients in cluster 1 experienced early onset of disease and myoclonus (A, B), whereas those in cluster 2 experienced more variable but predominantly late onset (C, D) of neurologic symptoms and myoclonus.